ISO 9001  
English Version Chinese Version
 
About Synmax Research and  Innovation Products and Markets Human Resources Contact Us
 
Research & Development
Partner Institution
FAQ
Patent
Home
 

   
Q
What is 7-ADCA?
A
7-ADCA is 7-amino deacetoxycephalosporanic acid for short. It is the intermediates for the ready synthesis if cephalosporins cefalexcin, cefadroxil and cefradine.
 
Q
What is the market value of 7-ADCA?
A
The requirement of 7-ADCA was 2,270 tonnes in 1997, and it is estimated that the requirement will be up to 2,800 tonnes in 2010. The market price of 7-ADCA so far is around $65/Kg, which means that the 7-ADCA business is ranging from $130 to 150 millions.
 
Q
Your company is executing the program "Development of a bioprocess for preparation of 7-ASDCA" partially supported by MOEA. What is the significance of this program?
A
The method currently used in industry to prepare 7-ADCA is to chemically expand the 5-membered ring of penicillin G to the 6-membered ring of cephalosporin G, then the latter is subjected to side-chain removal catalyzed by penicillin G acylase. It has been a great effort to replace this chemical process with enzymatic reaction because of its high impact to the envirement and high ratio of the cost. In this program, we are going to exploit the enzyme expandase in the ring expansion reaction, which has been studied for more than 20 years in other companies and there was no great success obtained. Obviously, if we can make it, it is not only impotant to us, but also to all the companies in this field.
 
Q
What is the expandase?
A
Expandase is a natural enzyme existed in the microorganisms which produce cephalosporins. Its main function is to convert the 5-membered ring containing compound penicillin N to the 6-membered ring containing compound deacetoxycephalosporanic acid (DAOC).
 
Q
Why it takes a long time to replace the chemical expasion reaction with the expandase?
A
Because the natural existed expandases only have a high activity to penicillin N, but low to the commercially available penicillin G. Acturally, the researchers even thought that the expandases did not have any activity toward penicillinjG until 1995.
 
Q
Since the expandase has a low activity to penicillin G, what is your approach to solve this problem?
A
Because the DNA sequence of the expandase and its crystal structure have been unveiled recently, our strategy is to clone the expandase gene first, then to make a random mutation on this gene by error prone PCR. So, the key point is how to select the mutated exzyme with high activity to penicillin G. Do we already develop the sreening method? The answer is yes. And we even got some high activity mutants, and the patent is filing.
 
   
Q
What is bioconversion ?
A
By clarifying the native biosynthetic ability of a microorganism in terms of genes and enzymes, we can genetically modify a microorganism to enable the microorganism modifying chemical structure of a substrate, so that the microorganism can produce useful target compound from natural or nonnatural substrate.
   
   
Q
What is ACE Inhibitors?
A
ACE inhibitors(angiotensin-converting enzyme inhibitors) prevent certain enzymes in the body from constricting blood vessels. This helps to lower blood pressure and makes the heart beat stronger. This medication is used to treat hypertension (high blood pressure) and heart failure.
   
Q
What is R-HPBA?
A
Chiral building block used as a versatile precursor for the synthesis of ACE-inhibitors.

 


Taipei Office: 10th Floor No. 10, Heng Yang Road, Taipei 100, Taiwan, R.O.C.
Tel:886-2-23881208    Fax:886-2-23820559
Factory: No. 238 Hsia Chung Tza, Yung-An Village, HsinWu Hsing, Taoyuan Hsien, Taiwan, R.O.C
Tel:886-3-486-3160    
Fax:886-3-486-3161